Patterns of progression on first line osimertinib in patients with EGFR mutation-positive advanced non-small cell lung cancer (NSCLC): A Swiss cohort study

Autor: Schuler, A., Huser, J., Schmid, S., Schär, S., Scherz, A., Gautschi, O., Mauti, L., von Briel, T., Waibel, C., Wannesson, L., Pankovics, J., Mark, M.T., Rothschild, S.I., Addeo, A., Janthur, W.D., Siano, M., Boos, L., Britschgi, C., Früh, M.

Publikováno v: In Lung Cancer January 2024 187

Real-world Experience with Capmatinib in MET Exon 14-mutated Non-small Cell Lung Cancer (RECAP)

Autor: Illini, O., Fabikan, H., Swalduz, A., Krenbek, D., Vikstrom, A., Schumacher, M., Dudnik, E., Studnicka, M., Ohman, R., Wurm, R., Wannesson, L., Peled, N., Kian, W., Bar, J., Daher, S., Addeo, A., Rotem, O., Pall, G., Zer, A., Saad, A., Cufer, T., Sorotsky, H. G., Hashemi, S. M. S., Mohorcic, K., Stoff, R., Rovitsky, Y., Keren-Rosenberg, S., Winder, T., Weinlinger, C., Valipour, A., Hochmair, M. J.

Publikováno v: Illini, O, Fabikan, H, Swalduz, A, Krenbek, D, Vikstrom, A, Schumacher, M, Dudnik, E, Studnicka, M, Ohman, R, Wurm, R, Wannesson, L, Peled, N, Kian, W, Bar, J, Daher, S, Addeo, A, Rotem, O, Pall, G, Zer, A, Saad, A, Cufer, T, Sorotsky, H G, Hashemi, S M S, Mohorcic, K, Stoff, R, Rovitsky, Y, Keren-Rosenberg, S, Winder, T, Weinlinger, C, Valipour, A & Hochmair, M J 2022, ' Real-world Experience with Capmatinib in MET Exon 14-mutated Non-small Cell Lung Cancer (RECAP) ', Journal of Thoracic Oncology, vol. 17, no. 9, pp. S460-S460 .
Journal of Thoracic Oncology, 17(9), S460-S460. International Association for the Study of Lung Cancer

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::3edf4f818230f06efbece638823d2977
https://research.vumc.nl/en/publications/257aeb33-e1d5-4456-afd1-4318a67e7361

Feasibility and safety of autotransplants with noncryopreserved marrow or peripheral blood stem cells: a systematic review

Autor: Wannesson, L. ^*, Panzarella, T., Mikhael, J., Keating, A.

Publikováno v: In Annals of Oncology April 2007 18(4):623-632

EP08.02-122 Real-world Experience with Capmatinib in MET Exon 14-mutated Non-small Cell Lung Cancer (RECAP)

Autor: Illini, O., Fabikan, H., Swalduz, A., Krenbek, D., Vikström, A., Schumacher, M., Dudnik, E., Studnicka, M., Öhman, R., Wurm, R., Wannesson, L., Peled, N., Kian, W., Bar, J., Daher, S., Addeo, A., Rotem, O., Pall, G., Zer, A., Saad, A., Cufer, T., Sorotsky, H.G., Hashemi, S.M.S., Mohorcic, K., Stoff, R., Rovitsky, Y., Keren-Rosenberg, S., Winder, T., Weinlinger, C., Valipour, A., Hochmair, M.J.

Publikováno v: In Journal of Thoracic Oncology September 2022 17(9) Supplement:S460-S460

MA16.01 Subsequent Systemic Therapy After Lurbinectedin Discontinuation in Patients With Small-cell Lung Cancer

Autor: Subbiah, V., Paz-Ares, L., Besse, B., Zaman, K., Sala, M.A., Fernández, C., Siguero, M., Kahatt, C., Lopez-Vilariño, J.A., Zeaiter, A., Arrondeau, J., Delord, J., Martínez, M., Wannesson, L., Antón, A., Trigo, J.M.

Publikováno v: In Journal of Thoracic Oncology October 2021 16(10) Supplement:S937-S938